Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Privi Speciality Chemicals Ltd (PRIVISCL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530117 NSE: PRIVISCL Chemicals | Small Cap | Privi SpecialityChem Share Price
₹3,685 1.90 (0.05%)
As on 15-Jul'26 14:38
Privi Speciality Chemicals Ltd (PRIVISCL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530117 NSE: PRIVISCL Chemicals | Small Cap | Privi SpecialityChem Share Price
₹3,685 1.90 (0.05%)
As on 15-Jul'26 14:38
Key Metrics
Valuation Multiples
Market Cap
₹14,387 Cr.
Current Price
₹3,685
52-Week Low / High
₹2,175 / 3,770
TTM EPS
₹91.5
TTM Sales
₹2,456 Cr.
Book Value per Share
₹368
P/E Ratio
40.25
Lower than its 5-year historical median
Industry PE
52.4
Price to Book (P/B)
10.01
Higher than its 5-year historical median
Price to Sales (P/S)
5.86
Higher than its 5-year historical median
EV/EBITDA
22.24
In line with its 5-year historical median
Dividend Yield
0.27%
Profitability Efficiency
Return on Equity (ROE)
28.16%
Outperforms industry median
Return on Capital Employed (ROCE)
26.68%
Outperforms industry median
Return on Assets (ROA)
13.35%
Operating Profit Margin
26.9%
Net Profit Margin
14.56%
Gross Profit Margin
24.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
20.47%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
47.48%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
88.82%
Asset Quality
Promoter Holding
60.60%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,399 Cr.
Equity
₹39.1 Cr.
Face Value
₹10
All Time Low / High
₹1.24 / 3770.00
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Strong
Is Privi Speciality Chemicals Ltd a good quality company?
Privi Speciality Chemicals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Privi Speciality Chemicals Ltd performance compare with that of its Peers?
Revenue growth of Privi Speciality Chemicals Ltd vs industry peers?
Privi Speciality Chemicals Ltd revenue CAGR is 9.50%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Privi Speciality Chemicals Ltd?
Promoters hold 60.60% of the Privi Speciality Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Privi Speciality Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 28.3% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Privi Speciality Chemicals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 17.2% | 22.2% | 22.4% | 36.2% | 15.7% | 11.1% | 5.6% | 12.5% | 18.1% | 26.7% | - |
| Value Creation Index ⓘ | 0.2 | 0.6 | 0.6 | 1.6 | 0.1 | -0.2 | -0.6 | -0.1 | 0.3 | 1.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 185 | 236 | 250 | 1,295 | 1,255 | 1,391 | 1,578 | 1,712 | 2,038 | 2,456 | 2,456 |
| Sales YoY Gr. | - | 27.5% | 5.7% | 418.1% | -3.1% | 10.9% | 13.4% | 8.5% | 19.1% | 20.5% | - |
| Adj EPS ⓘ | 2.4 | 5.2 | 5.6 | 26.1 | 22.5 | 19.8 | 2.6 | 21.7 | 46.2 | 89 | 91.5 |
| YoY Gr. | - | 113.6% | 8.1% | 367.1% | -13.9% | -12% | -86.9% | 735.8% | 112.6% | 92.6% | - |
| BVPS (₹) ⓘ | 18.8 | 22.8 | 26.3 | 154.3 | 182.8 | 206.7 | 210.6 | 235.6 | 281.9 | 368 | 368 |
| Adj Net Profit ⓘ | 9.1 | 19.5 | 21.8 | 102 | 87.9 | 77.3 | 10.2 | 84.9 | 180 | 347 | 357 |
| Cash Flow from Ops. ⓘ | 3.8 | 15.5 | 34.2 | 216 | 152 | 14.8 | 54.7 | 362 | 304 | 559 | - |
| Debt/CF from Ops. ⓘ | 15.4 | 4.2 | 1.7 | 2.2 | 3.4 | 59.5 | 18.7 | 2.4 | 2.8 | 1.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 33.3% | 14.4% | 15.9% | 20.5% | ||||
| Adj EPS ⓘ | 49.3% | 31.7% | 224.6% | 92.6% | ||||
| BVPSⓘ | 39.2% | 15% | 20.5% | 30.6% | ||||
| Share Price | 25.7% | 21.9% | 50.4% | 50.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 13.5 | 24.4 | 23 | 28.9 | 13.3 | 10.2 | 1.3 | 9.7 | 17.9 | 27.4 | 24.9 |
| Op. Profit Mgn % ⓘ | 12.8 | 14.3 | 14.6 | 16.6 | 16.5 | 14.1 | 11.6 | 19.2 | 22 | 26.9 | 26.8 |
| Net Profit Mgn % ⓘ | 4.9 | 8.2 | 8.7 | 7.9 | 7 | 5.6 | 0.6 | 5 | 8.9 | 14.2 | 14.6 |
| Debt to Equity ⓘ | 0.8 | 0.8 | 0.6 | 0.8 | 0.7 | 1.1 | 1.3 | 1 | 0.8 | 0.5 | 0.2 |
| Working Cap Days ⓘ | 83 | 95 | 103 | 100 | 198 | 228 | 256 | 243 | 215 | 210 | 97 |
| Cash Conv. Cycle ⓘ | 61 | 71 | 78 | 55 | 100 | 114 | 149 | 150 | 135 | 121 | 24 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 185 | 236 | 250 | 1,295 | 1,255 | 1,391 | 1,578 | 1,712 | 2,038 | 2,456 |
| Operating Expenses ⓘ + | 162 | 203 | 214 | 1,080 | 1,048 | 1,195 | 1,395 | 1,383 | 1,590 | 1,795 |
| Operating Profit ⓘ | 24 | 34 | 36 | 215 | 207 | 197 | 183 | 329 | 448 | 661 |
| Operating Profit Margin (%) | 12.8% | 14.3% | 14.4% | 16.6% | 16.5% | 14.1% | 11.6% | 19.2% | 22.0% | 26.9% |
| Other Income ⓘ + | 0 | 3 | 4 | 26 | 20 | 33 | 22 | 22 | 18 | 17 |
| Interest ⓘ | 5 | 6 | 6 | 37 | 23 | 25 | 68 | 97 | 85 | 68 |
| Depreciation ⓘ | 4 | 5 | 5 | 55 | 69 | 73 | 105 | 122 | 127 | 130 |
| Profit Before Tax ⓘ | 15 | 26 | 29 | 189 | 158 | 137 | 31 | 132 | 254 | 479 |
| Tax ⓘ | 6 | 6 | 8 | 45 | 41 | 35 | 9 | 34 | 65 | 122 |
| Profit After Tax | 9 | 19 | 22 | 144 | 117 | 102 | 22 | 98 | 189 | 357 |
| PAT Margin (%) | 4.9% | 8.2% | 8.6% | 11.1% | 9.3% | 7.3% | 1.4% | 5.7% | 9.3% | 14.6% |
| Adjusted EPS (₹) | 2.4 | 5.2 | 5.5 | 36.9 | 30.0 | 26.0 | 5.8 | 25.1 | 48.5 | 91.5 |
| Dividend Payout Ratio (%) | 41.50% | 29.10% | 45.40% | 4.10% | 6.70% | 7.70% | 0% | 8% | 10.30% | 10.90% |
Valuation of Privi SpecialityChem - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 72 | 87 | 103 | 603 | 714 | 807 | 822 | 920 | 1,101 | 1,438 | |
| Debt + | 50 | 55 | 49 | 462 | 474 | 816 | 922 | 747 | 711 | 615 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 6 | 7 | 10 | 157 | 180 | 308 | 298 | 283 | 405 | 552 | |
| Others Liabilities ⓘ | 25 | 27 | 27 | 142 | 154 | 197 | 301 | 238 | 257 | 278 | |
| Total Liabilities ⓘ | 154 | 176 | 188 | 1,364 | 1,522 | 2,128 | 2,343 | 2,189 | 2,473 | 2,883 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 94 | 102 | 115 | 564 | 565 | 666 | 982 | 999 | 979 | 1,005 | |
| CWIP ⓘ | 3 | 3 | 1 | 30 | 174 | 370 | 93 | 27 | 70 | 234 | |
| Investments ⓘ | 0 | 0 | 0 | 43 | 43 | 51 | 51 | 62 | 62 | 112 | |
| Inventories | 23 | 30 | 34 | 308 | 315 | 561 | 745 | 603 | 723 | 735 | |
| Trade Receivables | 25 | 32 | 32 | 217 | 236 | 284 | 314 | 361 | 401 | 586 | |
| Cash Equivalents | 0 | 0 | 0 | 85 | 15 | 31 | 14 | 20 | 41 | 34 | |
| Others Assets ⓘ | 8 | 9 | 6 | 117 | 173 | 166 | 143 | 117 | 198 | 176 | |
| Total Assets ⓘ | 154 | 176 | 188 | 1,364 | 1,522 | 2,128 | 2,343 | 2,189 | 2,473 | 2,883 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 4 | 15 | 34 | 216 | 152 | 15 | 55 | 362 | 304 | 559 |
| Cash Flow From Investing Activity ⓘ + | -20 | -13 | -14 | -174 | -242 | -324 | -141 | -118 | -144 | -354 |
| Cash Flow From Financing Activity ⓘ + | 17 | -3 | -21 | 29 | 19 | 324 | 70 | -239 | -135 | -212 |
| Net Cash Flow ⓘ | 0 | -0 | -0 | 72 | -71 | 15 | -16 | 5 | 25 | -7 |
Financial Ratio
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 13.54 | 24.8 | 22.83 | 40.83 | 17.77 | 13.37 | 2.76 | 11.23 | 18.73 | 28.16 |
| ROCE (%) | 17.15 | 22.24 | 22.38 | 36.24 | 15.65 | 11.12 | 5.63 | 12.52 | 18.09 | 26.68 |
| Asset Turnover Ratio | 1.52 | 1.48 | 1.38 | 1.67 | 0.87 | 0.76 | 0.71 | 0.76 | 0.87 | 0.92 |
| PAT to CFO Conversion(x) | 0.44 | 0.79 | 1.55 | 1.5 | 1.3 | 0.15 | 2.5 | 3.69 | 1.61 | 1.57 |
| Working Capital Days | ||||||||||
| Receivable Days | 38.20 | 42.80 | 46.50 | 35.10 | 65.80 | 68.20 | 69.20 | 72 | 68.20 | 73.40 |
| Inventory Days | 32.70 | 39.90 | 46.70 | 48.10 | 90.40 | 114.80 | 151.10 | 143.70 | 118.70 | 108.30 |
| Payable Days | 13.20 | 15.60 | 19.50 | 39.40 | 84.90 | 110.70 | 119.10 | 96.90 | 81.20 | 95.50 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Privi Speciality Chemicals Ltd FAQs
The current trading price of Privi SpecialityChem on 15-Jul-2026 14:38 is ₹3,685.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Jul-2026 the market cap of Privi SpecialityChem stood at ₹14,387.2 Cr
The latest P/E ratio of Privi SpecialityChem as of 14-Jul-2026 is 40.25.
The latest P/B ratio of Privi SpecialityChem as of 14-Jul-2026 is 10.01.
The 52-week high of Privi SpecialityChem is ₹3,770 and the 52-week low is ₹2,175.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Privi SpecialityChem is ₹2,456 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Privi Speciality Chemicals Ltd is a average quality company.
The key valuation ratios of Privi Speciality Chemicals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Privi Speciality Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Privi Speciality Chemicals Ltd
H. K. Finechem is a manufacturing company located near the city of Ahmedabad in the western region of India. Their company utilizes state of the art technology with critical equipments acquired from Germany and Switzerland. Fractions of natural oils and fats such as soyabean, sunflower and cottonseed are the source of the company's fine chemical products. They specialize in oleo chemicals and products for the nutraceutical industry. Their hallmark has been consistent supply of products of superior quality in India, USA, Europe and Japan.
H. K. Finechem is a technology driven company. It has faced the challenges successfully to commercialize products which would help customers in increasing efficiency, reducing cost and minimizing environmental impact.
Their products are manufactured and marketed in a safe and socially acceptable manner by meeting legal obligations.
The company continuously strive to improve quality which is achieved with the help of a sophisticated laboratory having the latest analytical equipments manned by experienced and dedicated personnel. It successfully manufactures quality products developed in-house for the first time in India using high vacuum technology in our modern manufacturing facility.
Product range of the company includes:
The Company's principal activity is to manufacture speciality oleo chemicals and products for the nutraceutical industry. The Company's main products are mixed tocopherols, sterols, linoleic acid, monobasic acid and dimer acid for polyamides and printing ink industry. It processes both the by product streams of vegetable oil refineries viz. vegetable oil based fatty acid distillate and acid oil.
OLEO Chemicals
- Dimer Fatty Acid
- Monomer Fatty Acid
- Linoleic Fatty Acid
- Soya Fatty Acid
- Saturated Fatty Acid
- Distilled Fatty Acid
- Glycerine
- Oil for Industrial Purpose
Intermediate Nutraceutical & Health Products
- Natural Concentrated Tocopherols
- Natural Concentratred Sterols
You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
